Notably, the expression of co-stimulatory molecule CD80 by DCs, critical for generating tumor-antigen-specific CD8+ T cells, follows a circadian pattern, contributing to the time-of-day dosage-dependent tumor-killing potential. The gene discussed is CD8A; the disease is neoplasm.